AR029547A1 - Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon - Google Patents
Composiciones y metodos para la terapia y el diagnostico de cancer de pulmonInfo
- Publication number
- AR029547A1 AR029547A1 ARP010103137A ARP010103137A AR029547A1 AR 029547 A1 AR029547 A1 AR 029547A1 AR P010103137 A ARP010103137 A AR P010103137A AR P010103137 A ARP010103137 A AR P010103137A AR 029547 A1 AR029547 A1 AR 029547A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- cancer
- methods
- diagnosis
- therapy
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 208000020816 lung neoplasm Diseases 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 208000037841 lung tumor Diseases 0.000 abstract 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 201000005202 lung cancer Diseases 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4634—Antigenic peptides; polypeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4637—Other peptides or polypeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/86—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/55—Lung
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Composiciones y métodos para la terapia y el diagnostico del cáncer, por ejemplo del cáncer de pulmon. Las composiciones pueden comprender una o más proteínas de tumor de pulmon, porciones inmunogénicas de las mismas, o polinucleotidos que codifican dichas porciones. Como alternativa, una composicion terapéutica puede comprender una célula que comprende una antígeno que expresa una proteína de tumor de pulmon, una célula T que es específica para las células que expresan dicha proteína. Las composiciones se pueden usar, por ejemplo, para la prevencion y tratamiento de enfermedades tales como el cáncer de pulmon. También se proveen métodos de diagnostico basados en la deteccion de una proteína de tumor de pulmon, o RNAm que codifica dicha proteína en una muestra.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21569600P | 2000-06-29 | 2000-06-29 | |
| US22714200P | 2000-08-22 | 2000-08-22 | |
| US23048100P | 2000-09-06 | 2000-09-06 | |
| US25772900P | 2000-12-21 | 2000-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029547A1 true AR029547A1 (es) | 2003-07-02 |
Family
ID=27499017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010103137A AR029547A1 (es) | 2000-06-29 | 2001-06-29 | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20020099012A1 (es) |
| EP (1) | EP1366157A2 (es) |
| JP (1) | JP2004524003A (es) |
| AR (1) | AR029547A1 (es) |
| AU (1) | AU2001273127A1 (es) |
| CA (1) | CA2414596A1 (es) |
| WO (1) | WO2002002623A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001266790A1 (en) * | 2000-06-09 | 2001-12-24 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| WO2003087154A2 (fr) * | 2002-04-12 | 2003-10-23 | Molecular Engines Laboratories | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
| AU2004224448A1 (en) * | 2003-03-24 | 2004-10-07 | Corixa Corporation | Detection and monitoring of lung cancer |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| US20060292600A1 (en) * | 2004-03-10 | 2006-12-28 | Corixa Corporation | Methods, compositions and kits for the detection and monitoring of lung cancer |
| EP1957672A2 (fr) * | 2005-10-28 | 2008-08-20 | Biomerieux Sa | Procede de detection du cancer |
| EP2806274A1 (en) * | 2013-05-24 | 2014-11-26 | AIT Austrian Institute of Technology GmbH | Lung cancer diagnostic method and means |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122373B1 (en) * | 1998-05-14 | 2006-10-17 | Nuvelo, Inc. | Human genes and gene expression products V |
| WO1999037660A1 (en) * | 1998-01-23 | 1999-07-29 | Beth Israel Deaconess Medical Center | Meth1 and meth2 polynucleotides and polypeptides |
| ID27813A (id) * | 1998-01-28 | 2001-04-26 | Corixa Corp | Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya |
| DE69933998T2 (de) * | 1998-03-18 | 2007-10-04 | Corixa Corp., Seattle | Verbindungen und verfahren für therapie und diagnose von lungenkrebs |
-
2001
- 2001-06-28 WO PCT/US2001/020975 patent/WO2002002623A2/en not_active Application Discontinuation
- 2001-06-28 US US09/895,828 patent/US20020099012A1/en not_active Abandoned
- 2001-06-28 EP EP01952367A patent/EP1366157A2/en not_active Withdrawn
- 2001-06-28 AU AU2001273127A patent/AU2001273127A1/en not_active Abandoned
- 2001-06-28 CA CA002414596A patent/CA2414596A1/en not_active Abandoned
- 2001-06-28 JP JP2002507874A patent/JP2004524003A/ja active Pending
- 2001-06-29 AR ARP010103137A patent/AR029547A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20020099012A1 (en) | 2002-07-25 |
| CA2414596A1 (en) | 2002-01-10 |
| EP1366157A2 (en) | 2003-12-03 |
| AU2001273127A1 (en) | 2002-01-14 |
| WO2002002623A3 (en) | 2003-10-02 |
| JP2004524003A (ja) | 2004-08-12 |
| WO2002002623A2 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032743A1 (es) | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon | |
| ATE353974T1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
| WO2001096388A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| WO2001096390A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
| WO2000060076A3 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
| AR031250A1 (es) | Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon | |
| WO2001079286A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| WO2001025272A3 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| WO2001034802A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| BR9912007A (pt) | Composições e métodos para terapia e diagnóstico de câncer de próstata | |
| WO2000060077A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
| WO2002083070A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
| WO2001073027A3 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
| WO2001049716A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
| AR029547A1 (es) | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon | |
| AR029540A1 (es) | COMPOSICIONES Y METODOS PARA EL DIAGNoSTICO Y LA TERAPIA DE CA NCER DE PULMoN | |
| WO2001057207A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| WO2000078960A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| MXPA02011563A (es) | Composicionesy metodos para la terapia y diagnostico de cancer de seno. | |
| WO2001051513A3 (en) | Ovarian tumor-associated sequences | |
| WO2001073031A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| WO2001096389A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| ATE435284T1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| WO2002045657A3 (en) | Ovarian tumor antigen and methods of use therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |